APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polymer Coronary Stents

Compare research editions
View pricing & licenses

Selected research

Industry Research

Polymer Coronary Stents Industry Research Report 2026

26 December 2025133 pages

Choose your research edition.

Industry ResearchPolymer Coronary Stents Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Polymer Coronary Stents Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Polymer Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polymer Coronary Stents Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Polymer Coronary Stents Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Polymer Coronary Stents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Polymer Coronary Stents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Polymer Coronary Stents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Polymer Coronary Stents include Wego Healthcare, Shandong Huaan Biotechnology, SINOMED, Translumina Therapeutics, SLTL Medical, Scitech Medical, Rontis, REVA Medical and Purple Microport, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Polymer Coronary Stents market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Polymer Coronary Stents Market by Company

Wego Healthcare

Shandong Huaan Biotechnology

SINOMED

Translumina Therapeutics

SLTL Medical

Scitech Medical

Rontis

REVA Medical

Purple Microport

Meril Life

InSitu Technologies

HEALTHCARE TECHNOLOGY

Eucatech

Elixir Medical

CeloNova BioSciences

Biotronik

AMG International

Amaranth Medical Analytics

Alvimedica

Polymer Coronary Stents Segment by Type

Hybrid Stents

Biodegradable Polymer Stents

Resorbable Polymer Stents

Bare Metal Polymer Stents

Drug-Eluting Polymer Stents

Polymer Coronary Stents Segment by Application

Drug-Eluting

Post-Procedure Management

Percutaneous Coronary Intervention (PCI)

Polymer Coronary Stents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymer Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymer Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymer Coronary Stents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Polymer Coronary Stents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Polymer Coronary Stents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Polymer Coronary Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Polymer Coronary Stents Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Polymer Coronary Stents Sales (Units) of Manufacturers (2021-2026) Table 7. Global Polymer Coronary Stents Sales Market Share by Manufacturers (2021-2026) Table 8. Global Polymer Coronary Stents Revenue of Manufacturers (2021-2026) Table 9. Global Polymer Coronary Stents Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Polymer Coronary Stents Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Polymer Coronary Stents Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Polymer Coronary Stents, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Polymer Coronary Stents, Product Type & Application Table 14. Global Polymer Coronary Stents Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Polymer Coronary Stents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Wego Healthcare Company Information Table 19. Wego Healthcare Business Overview Table 20. Wego Healthcare Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Wego Healthcare Polymer Coronary Stents Product Portfolio Table 22. Wego Healthcare Recent Developments Table 23. Shandong Huaan Biotechnology Company Information Table 24. Shandong Huaan Biotechnology Business Overview Table 25. Shandong Huaan Biotechnology Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Shandong Huaan Biotechnology Polymer Coronary Stents Product Portfolio Table 27. Shandong Huaan Biotechnology Recent Developments Table 28. SINOMED Company Information Table 29. SINOMED Business Overview Table 30. SINOMED Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. SINOMED Polymer Coronary Stents Product Portfolio Table 32. SINOMED Recent Developments Table 33. Translumina Therapeutics Company Information Table 34. Translumina Therapeutics Business Overview Table 35. Translumina Therapeutics Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Translumina Therapeutics Polymer Coronary Stents Product Portfolio Table 37. Translumina Therapeutics Recent Developments Table 38. SLTL Medical Company Information Table 39. SLTL Medical Business Overview Table 40. SLTL Medical Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. SLTL Medical Polymer Coronary Stents Product Portfolio Table 42. SLTL Medical Recent Developments Table 43. Scitech Medical Company Information Table 44. Scitech Medical Business Overview Table 45. Scitech Medical Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Scitech Medical Polymer Coronary Stents Product Portfolio Table 47. Scitech Medical Recent Developments Table 48. Rontis Company Information Table 49. Rontis Business Overview Table 50. Rontis Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Rontis Polymer Coronary Stents Product Portfolio Table 52. Rontis Recent Developments Table 53. REVA Medical Company Information Table 54. REVA Medical Business Overview Table 55. REVA Medical Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. REVA Medical Polymer Coronary Stents Product Portfolio Table 57. REVA Medical Recent Developments Table 58. Purple Microport Company Information Table 59. Purple Microport Business Overview Table 60. Purple Microport Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Purple Microport Polymer Coronary Stents Product Portfolio Table 62. Purple Microport Recent Developments Table 63. Meril Life Company Information Table 64. Meril Life Business Overview Table 65. Meril Life Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Meril Life Polymer Coronary Stents Product Portfolio Table 67. Meril Life Recent Developments Table 68. InSitu Technologies Company Information Table 69. InSitu Technologies Business Overview Table 70. InSitu Technologies Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. InSitu Technologies Polymer Coronary Stents Product Portfolio Table 72. InSitu Technologies Recent Developments Table 73. HEALTHCARE TECHNOLOGY Company Information Table 74. HEALTHCARE TECHNOLOGY Business Overview Table 75. HEALTHCARE TECHNOLOGY Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. HEALTHCARE TECHNOLOGY Polymer Coronary Stents Product Portfolio Table 77. HEALTHCARE TECHNOLOGY Recent Developments Table 78. Eucatech Company Information Table 79. Eucatech Business Overview Table 80. Eucatech Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Eucatech Polymer Coronary Stents Product Portfolio Table 82. Eucatech Recent Developments Table 83. Elixir Medical Company Information Table 84. Elixir Medical Business Overview Table 85. Elixir Medical Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Elixir Medical Polymer Coronary Stents Product Portfolio Table 87. Elixir Medical Recent Developments Table 88. CeloNova BioSciences Company Information Table 89. CeloNova BioSciences Business Overview Table 90. CeloNova BioSciences Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. CeloNova BioSciences Polymer Coronary Stents Product Portfolio Table 92. CeloNova BioSciences Recent Developments Table 93. Biotronik Company Information Table 94. Biotronik Business Overview Table 95. Biotronik Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Biotronik Polymer Coronary Stents Product Portfolio Table 97. Biotronik Recent Developments Table 98. AMG International Company Information Table 99. AMG International Business Overview Table 100. AMG International Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AMG International Polymer Coronary Stents Product Portfolio Table 102. AMG International Recent Developments Table 103. Amaranth Medical Analytics Company Information Table 104. Amaranth Medical Analytics Business Overview Table 105. Amaranth Medical Analytics Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Amaranth Medical Analytics Polymer Coronary Stents Product Portfolio Table 107. Amaranth Medical Analytics Recent Developments Table 108. Alvimedica Company Information Table 109. Alvimedica Business Overview Table 110. Alvimedica Polymer Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Alvimedica Polymer Coronary Stents Product Portfolio Table 112. Alvimedica Recent Developments Table 113. Global Polymer Coronary Stents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Polymer Coronary Stents Sales by Region (2021-2026) & (Units) Table 115. Global Polymer Coronary Stents Sales Market Share by Region (2021-2026) Table 116. Global Polymer Coronary Stents Sales by Region (2027-2032) & (Units) Table 117. Global Polymer Coronary Stents Sales Market Share by Region (2027-2032) Table 118. Global Polymer Coronary Stents Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Polymer Coronary Stents Revenue Market Share by Region (2021-2026) Table 120. Global Polymer Coronary Stents Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Polymer Coronary Stents Revenue Market Share by Region (2027-2032) Table 122. North America Polymer Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 124. North America Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 125. North America Polymer Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Polymer Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Polymer Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 129. Europe Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 130. Europe Polymer Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Polymer Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Polymer Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 134. Asia Pacific Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 135. Asia Pacific Polymer Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Polymer Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Polymer Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 139. South America Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 140. South America Polymer Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Polymer Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Polymer Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 144. Middle East and Africa Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 145. Middle East and Africa Polymer Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Polymer Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Polymer Coronary Stents Sales by Type (2021-2026) & (Units) Table 148. Global Polymer Coronary Stents Sales by Type (2027-2032) & (Units) Table 149. Global Polymer Coronary Stents Sales Market Share by Type (2021-2026) Table 150. Global Polymer Coronary Stents Sales Market Share by Type (2027-2032) Table 151. Global Polymer Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Polymer Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Polymer Coronary Stents Revenue Market Share by Type (2021-2026) Table 154. Global Polymer Coronary Stents Revenue Market Share by Type (2027-2032) Table 155. Global Polymer Coronary Stents Price by Type (2021-2026) & (US$/Unit) Table 156. Global Polymer Coronary Stents Price by Type (2027-2032) & (US$/Unit) Table 157. Global Polymer Coronary Stents Sales by Application (2021-2026) & (Units) Table 158. Global Polymer Coronary Stents Sales by Application (2027-2032) & (Units) Table 159. Global Polymer Coronary Stents Sales Market Share by Application (2021-2026) Table 160. Global Polymer Coronary Stents Sales Market Share by Application (2027-2032) Table 161. Global Polymer Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Polymer Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Polymer Coronary Stents Revenue Market Share by Application (2021-2026) Table 164. Global Polymer Coronary Stents Revenue Market Share by Application (2027-2032) Table 165. Global Polymer Coronary Stents Price by Application (2021-2026) & (US$/Unit) Table 166. Global Polymer Coronary Stents Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Polymer Coronary Stents Distributors List Table 170. Polymer Coronary Stents Customers List Table 171. Polymer Coronary Stents Industry Trends Table 172. Polymer Coronary Stents Industry Drivers Table 173. Polymer Coronary Stents Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Polymer Coronary Stents Product Image Figure 5. Global Polymer Coronary Stents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Polymer Coronary Stents Market Size (2021-2032) & (US$ Million) Figure 7. Global Polymer Coronary Stents Sales (2021-2032) & (Units) Figure 8. Global Polymer Coronary Stents Average Price (US$/Unit) & (2021-2032) Figure 9. Hybrid Stents Product Image Figure 10. Biodegradable Polymer Stents Product Image Figure 11. Resorbable Polymer Stents Product Image Figure 12. Bare Metal Polymer Stents Product Image Figure 13. Drug-Eluting Polymer Stents Product Image Figure 14. Drug-Eluting Product Image Figure 15. Post-Procedure Management Product Image Figure 16. Percutaneous Coronary Intervention (PCI) Product Image Figure 17. Global Polymer Coronary Stents Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Polymer Coronary Stents, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Polymer Coronary Stents Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Polymer Coronary Stents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Polymer Coronary Stents Sales by Region in 2025 Figure 23. Global Polymer Coronary Stents Revenue by Region in 2025 Figure 24. North America Polymer Coronary Stents Market Size by Country in 2025 Figure 25. North America Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 26. North America Polymer Coronary Stents Revenue Market Share by Country (2021-2032) Figure 27. United States Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Polymer Coronary Stents Market Size by Country in 2025 Figure 31. Europe Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 32. Europe Polymer Coronary Stents Revenue Market Share by Country (2021-2032) Figure 33. Germany Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Polymer Coronary Stents Market Size by Country in 2025 Figure 44. Asia Pacific Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Polymer Coronary Stents Revenue Market Share by Country (2021-2032) Figure 46. China Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Polymer Coronary Stents Market Size by Country in 2025 Figure 55. South America Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 56. South America Polymer Coronary Stents Revenue Market Share by Country (2021-2032) Figure 57. Brazil Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Polymer Coronary Stents Market Size by Country in 2025 Figure 61. Middle East and Africa Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Polymer Coronary Stents Revenue Market Share by Country (2021-2032) Figure 63. Egypt Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Polymer Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Polymer Coronary Stents Sales Market Share by Type (2021-2032) Figure 69. Global Polymer Coronary Stents Revenue Market Share by Type (2021-2032) Figure 70. Global Polymer Coronary Stents Price (US$/Unit) by Type (2021-2032) Figure 71. Global Polymer Coronary Stents Sales Market Share by Application (2021-2032) Figure 72. Global Polymer Coronary Stents Revenue Market Share by Application (2021-2032) Figure 73. Global Polymer Coronary Stents Price (US$/Unit) by Application (2021-2032) Figure 74. Polymer Coronary Stents Value Chain Figure 75. Polymer Coronary Stents Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Polymer Coronary Stents Industry Opportunities and Challenges

Scope & coverage.

Types
  • Hybrid Stents
  • Biodegradable Polymer Stents
  • Resorbable Polymer Stents
  • Bare Metal Polymer Stents
  • Drug-Eluting Polymer Stents
Applications
  • Drug-Eluting
  • Post-Procedure Management
  • Percutaneous Coronary Intervention (PCI)
Companies covered
  • Wego Healthcare
  • Shandong Huaan Biotechnology
  • SINOMED
  • Translumina Therapeutics
  • SLTL Medical
  • Scitech Medical
  • Rontis
  • REVA Medical
  • Purple Microport
  • Meril Life
  • InSitu Technologies
  • HEALTHCARE TECHNOLOGY
  • Eucatech
  • Elixir Medical
  • CeloNova BioSciences
  • Biotronik
  • AMG International
  • Amaranth Medical Analytics
  • Alvimedica

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Polymer Coronary Stents Market Size (2021-2032)
  4. 2.2.2 Global Polymer Coronary Stents Sales (2021-2032)
  5. 2.2.3 Global Polymer Coronary Stents Market Average Price (2021-2032)
  6. 2.3 Polymer Coronary Stents by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Hybrid Stents
  9. 2.3.3 Biodegradable Polymer Stents
  10. 2.3.4 Resorbable Polymer Stents
  11. 2.3.5 Bare Metal Polymer Stents
  12. 2.3.6 Drug-Eluting Polymer Stents
  13. 2.4 Polymer Coronary Stents by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Drug-Eluting
  16. 2.4.3 Post-Procedure Management
  17. 2.4.4 Percutaneous Coronary Intervention (PCI)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Polymer Coronary Stents Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Polymer Coronary Stents Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Polymer Coronary Stents Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Polymer Coronary Stents Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Polymer Coronary Stents Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Polymer Coronary Stents, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Polymer Coronary Stents, Product Type & Application
  8. 3.8 Global Manufacturers of Polymer Coronary Stents, Established Date
  9. 3.9 Global Polymer Coronary Stents Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Wego Healthcare
  2. 4.1.1 Wego Healthcare Company Information
  3. 4.1.2 Wego Healthcare Business Overview
  4. 4.1.3 Wego Healthcare Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Wego Healthcare Polymer Coronary Stents Product Portfolio
  6. 4.1.5 Wego Healthcare Recent Developments
  7. 4.2 Shandong Huaan Biotechnology
  8. 4.2.1 Shandong Huaan Biotechnology Company Information
  9. 4.2.2 Shandong Huaan Biotechnology Business Overview
  10. 4.2.3 Shandong Huaan Biotechnology Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shandong Huaan Biotechnology Polymer Coronary Stents Product Portfolio
  12. 4.2.5 Shandong Huaan Biotechnology Recent Developments
  13. 4.3 SINOMED
  14. 4.3.1 SINOMED Company Information
  15. 4.3.2 SINOMED Business Overview
  16. 4.3.3 SINOMED Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 SINOMED Polymer Coronary Stents Product Portfolio
  18. 4.3.5 SINOMED Recent Developments
  19. 4.4 Translumina Therapeutics
  20. 4.4.1 Translumina Therapeutics Company Information
  21. 4.4.2 Translumina Therapeutics Business Overview
  22. 4.4.3 Translumina Therapeutics Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Translumina Therapeutics Polymer Coronary Stents Product Portfolio
  24. 4.4.5 Translumina Therapeutics Recent Developments
  25. 4.5 SLTL Medical
  26. 4.5.1 SLTL Medical Company Information
  27. 4.5.2 SLTL Medical Business Overview
  28. 4.5.3 SLTL Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 SLTL Medical Polymer Coronary Stents Product Portfolio
  30. 4.5.5 SLTL Medical Recent Developments
  31. 4.6 Scitech Medical
  32. 4.6.1 Scitech Medical Company Information
  33. 4.6.2 Scitech Medical Business Overview
  34. 4.6.3 Scitech Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Scitech Medical Polymer Coronary Stents Product Portfolio
  36. 4.6.5 Scitech Medical Recent Developments
  37. 4.7 Rontis
  38. 4.7.1 Rontis Company Information
  39. 4.7.2 Rontis Business Overview
  40. 4.7.3 Rontis Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Rontis Polymer Coronary Stents Product Portfolio
  42. 4.7.5 Rontis Recent Developments
  43. 4.8 REVA Medical
  44. 4.8.1 REVA Medical Company Information
  45. 4.8.2 REVA Medical Business Overview
  46. 4.8.3 REVA Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 REVA Medical Polymer Coronary Stents Product Portfolio
  48. 4.8.5 REVA Medical Recent Developments
  49. 4.9 Purple Microport
  50. 4.9.1 Purple Microport Company Information
  51. 4.9.2 Purple Microport Business Overview
  52. 4.9.3 Purple Microport Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Purple Microport Polymer Coronary Stents Product Portfolio
  54. 4.9.5 Purple Microport Recent Developments
  55. 4.10 Meril Life
  56. 4.10.1 Meril Life Company Information
  57. 4.10.2 Meril Life Business Overview
  58. 4.10.3 Meril Life Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Meril Life Polymer Coronary Stents Product Portfolio
  60. 4.10.5 Meril Life Recent Developments
  61. 4.11 InSitu Technologies
  62. 4.11.1 InSitu Technologies Company Information
  63. 4.11.2 InSitu Technologies Business Overview
  64. 4.11.3 InSitu Technologies Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 InSitu Technologies Polymer Coronary Stents Product Portfolio
  66. 4.11.5 InSitu Technologies Recent Developments
  67. 4.12 HEALTHCARE TECHNOLOGY
  68. 4.12.1 HEALTHCARE TECHNOLOGY Company Information
  69. 4.12.2 HEALTHCARE TECHNOLOGY Business Overview
  70. 4.12.3 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Product Portfolio
  72. 4.12.5 HEALTHCARE TECHNOLOGY Recent Developments
  73. 4.13 Eucatech
  74. 4.13.1 Eucatech Company Information
  75. 4.13.2 Eucatech Business Overview
  76. 4.13.3 Eucatech Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Eucatech Polymer Coronary Stents Product Portfolio
  78. 4.13.5 Eucatech Recent Developments
  79. 4.14 Elixir Medical
  80. 4.14.1 Elixir Medical Company Information
  81. 4.14.2 Elixir Medical Business Overview
  82. 4.14.3 Elixir Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Elixir Medical Polymer Coronary Stents Product Portfolio
  84. 4.14.5 Elixir Medical Recent Developments
  85. 4.15 CeloNova BioSciences
  86. 4.15.1 CeloNova BioSciences Company Information
  87. 4.15.2 CeloNova BioSciences Business Overview
  88. 4.15.3 CeloNova BioSciences Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CeloNova BioSciences Polymer Coronary Stents Product Portfolio
  90. 4.15.5 CeloNova BioSciences Recent Developments
  91. 4.16 Biotronik
  92. 4.16.1 Biotronik Company Information
  93. 4.16.2 Biotronik Business Overview
  94. 4.16.3 Biotronik Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Biotronik Polymer Coronary Stents Product Portfolio
  96. 4.16.5 Biotronik Recent Developments
  97. 4.17 AMG International
  98. 4.17.1 AMG International Company Information
  99. 4.17.2 AMG International Business Overview
  100. 4.17.3 AMG International Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 AMG International Polymer Coronary Stents Product Portfolio
  102. 4.17.5 AMG International Recent Developments
  103. 4.18 Amaranth Medical Analytics
  104. 4.18.1 Amaranth Medical Analytics Company Information
  105. 4.18.2 Amaranth Medical Analytics Business Overview
  106. 4.18.3 Amaranth Medical Analytics Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Amaranth Medical Analytics Polymer Coronary Stents Product Portfolio
  108. 4.18.5 Amaranth Medical Analytics Recent Developments
  109. 4.19 Alvimedica
  110. 4.19.1 Alvimedica Company Information
  111. 4.19.2 Alvimedica Business Overview
  112. 4.19.3 Alvimedica Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Alvimedica Polymer Coronary Stents Product Portfolio
  114. 4.19.5 Alvimedica Recent Developments
5 Global Polymer Coronary Stents Market Scenario by Region
  1. 5.1 Global Polymer Coronary Stents Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Polymer Coronary Stents Sales by Region: 2021-2032
  3. 5.2.1 Global Polymer Coronary Stents Sales by Region: 2021-2026
  4. 5.2.2 Global Polymer Coronary Stents Sales by Region: 2027-2032
  5. 5.3 Global Polymer Coronary Stents Revenue by Region: 2021-2032
  6. 5.3.1 Global Polymer Coronary Stents Revenue by Region: 2021-2026
  7. 5.3.2 Global Polymer Coronary Stents Revenue by Region: 2027-2032
  8. 5.4 North America Polymer Coronary Stents Market Facts & Figures by Country
  9. 5.4.1 North America Polymer Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Polymer Coronary Stents Sales by Country (2021-2032)
  11. 5.4.3 North America Polymer Coronary Stents Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Polymer Coronary Stents Market Facts & Figures by Country
  16. 5.5.1 Europe Polymer Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Polymer Coronary Stents Sales by Country (2021-2032)
  18. 5.5.3 Europe Polymer Coronary Stents Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Polymer Coronary Stents Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Polymer Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Polymer Coronary Stents Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Polymer Coronary Stents Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Polymer Coronary Stents Market Facts & Figures by Country
  41. 5.7.1 South America Polymer Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Polymer Coronary Stents Sales by Country (2021-2032)
  43. 5.7.3 South America Polymer Coronary Stents Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Polymer Coronary Stents Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Polymer Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Polymer Coronary Stents Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Polymer Coronary Stents Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Polymer Coronary Stents Sales by Type (2021-2032)
  2. 6.1.1 Global Polymer Coronary Stents Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Polymer Coronary Stents Sales Market Share by Type (2021-2032)
  4. 6.2 Global Polymer Coronary Stents Revenue by Type (2021-2032)
  5. 6.2.1 Global Polymer Coronary Stents Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Polymer Coronary Stents Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Polymer Coronary Stents Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Polymer Coronary Stents Sales by Application (2021-2032)
  2. 7.1.1 Global Polymer Coronary Stents Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Polymer Coronary Stents Sales Market Share by Application (2021-2032)
  4. 7.2 Global Polymer Coronary Stents Revenue by Application (2021-2032)
  5. 7.2.1 Global Polymer Coronary Stents Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Polymer Coronary Stents Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Polymer Coronary Stents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Polymer Coronary Stents Value Chain Analysis
  2. 8.1.1 Polymer Coronary Stents Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Polymer Coronary Stents Production Mode & Process
  5. 8.2 Polymer Coronary Stents Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Polymer Coronary Stents Distributors
  8. 8.2.3 Polymer Coronary Stents Customers
9 Global Polymer Coronary Stents Analyzing Market Dynamics
  1. 9.1 Polymer Coronary Stents Industry Trends
  2. 9.2 Polymer Coronary Stents Industry Drivers
  3. 9.3 Polymer Coronary Stents Industry Opportunities and Challenges
  4. 9.4 Polymer Coronary Stents Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst